KorrekturOpen access · CC BY 4.0
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”
Advanced Science · 2026-06 · 13 (33)
DOI: 10.1002/advs.75571 ↗At a glance
Korrektur in Advanced Science, published online on 2026-05-07. The full text is freely available (open access, CC BY 4.0).
Abstract (original language)
Není k dispozici žádný abstrakt.
Cite
APA
(2026). Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science, 13(33). https://doi.org/10.1002/advs.75571
Vancouver
Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”. Advanced Science. 2026;13(33). doi:10.1002/advs.75571
BibTeX
@article{euvimed2026,
title = {Correction to “Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer”},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {33},
doi = {10.1002/advs.75571}
}
EUVIMED